White Paper: New European Health Technology Assessment Regulation

In December 2021, the European Commission adopted the new European Health Technology Assessment Regulation, requiring clinical submissions at the European level, nearly four years after it was initially proposed in January 2018. Ultimately aimed at strengthening cooperation among European HTA agencies, the new regulation will have a progressive implementation, from 2025 to 2030.

The European Health Technology Assessment Regulation is now in place, making it mandatory for manufacturers to submit a clinical dossier at European level from 2025.

It’s important for pharma, biotech and medtech companies to be aware of this new joint assessment methodology (including type of comparators, evidence requested, and stakeholders involved) to understand the level of effort for the joint work by Member States – and what effect that has on access to new medicine.

In this white paper, we provide an overview of this new regulation, including key points of the new European Health Technology Assessment Regulation, its methodology, and its timelines.

Publications
Published on:
August 4, 2022
Written by:
Nerea Blanqué-Catalina, Marta Aguado

Do you have any questions about the white paper “New European Health Technology Assessment Regulation”?

Related news

Multimedia March 24, 2023
MedTech CDMO: Market and M&A Trends in the U.S. in 2023
Join us for this exciting webinar to learn about the current trends shaping the US medical device outsourcing landscape, with a particular focus on its performance and business outlook,(...)
CDMO MedTech
Multimedia March 22, 2023
The MedTech World Podcast: Interview with Gabriele Brambilla
Gabriele Brambilla, CEO of Alira Health, has joined the MedTech World Podcast to discuss his experiences and journey in the Healthcare industry.
Digital Health MedTech
Blog March 14, 2023
Silicon Valley Bank and the Healthcare Ecosystem
In light of the Silicon Valley Bank collapse, we reached out to Alira Health Partner Deepak Sahu for his insight into the situation.
Health Economics Innovation MedTech
Blog March 6, 2023
Market Access in Catalonia: 2022 Trends and What’s Next
Alira Health contributed to the recently published 2022 BioRegion Report, the most extensive analysis of the assets, achievements, and trends in the life sciences and healthcare sector(...)
Biotech Market Access MedTech
Events March 1, 2023
Emerging Medtech Summit 2023
We are excited to announce that we will attend and speak at Emerging Medtech Summit 2023, the must-attend medtech partnering and investment event for leading medtech startup CEOs, investors(...)
MedTech Startups
Events February 28, 2023
2023 MedTech Color Pitch Competition
We are proud to share that we are partnering with 2023 MedTech Color Pitch Competition. The MedTech Color Pitch Competition searches for the next generation of fearless founders innovating(...)
MedTech Startups
News February 27, 2023
Alira Health Partners with MedTech Innovator to Help Accelerate Startup Growth
Alira Health is pleased to partner with MedTech Innovator on their joint mission to improve the lives of patients by accelerating the growth of companies that are transforming the healthcare system.
Innovation MedTech Startups
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.